Public library - UKHSA national
Restricted group
|
Started - August 2018
|
Last activity - November
Back
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England
Version 1.3 Approved
Owner
- Document Type
- Basic Document
- Extension
- Size
- 285 KB
- Modified
- 15/11/21 13:24 by PHE Publishing
- Created
- 15/11/21 09:13 by PHE Publishing
- Ratings
-
0
application/pdf; version=1.7
2021-11-15T13:23:51Z
UKHSA
2021-11-15T13:23:51Z
en-GB
COVID-19; coronavirus; BNT162b2; Comirnaty, Pfizer-BioNTech
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against COVID-19 related symptoms in England: test negative case-control study
application/pdf
2021-11-15T13:23:51Z
COVID-19; coronavirus; BNT162b2; Comirnaty, Pfizer-BioNTech
UKHSA
2021-11-15T13:23:51Z
2021-11-15T13:23:51Z
-
Version 1.3By PHE Publishing, on 15/11/21 13:24No Change Log
-
Version 1.2By PHE Publishing, on 15/11/21 09:22No Change Log
-
Version 1.1By PHE Publishing, on 15/11/21 09:22No Change Log
-
Version 1.0By PHE Publishing, on 15/11/21 09:13No Change Log